Inherited monogenic defects of ceramide metabolism: Molecular bases and diagnoses
- 1 August 2019
- journal article
- review article
- Published by Elsevier in Clinica Chimica Acta
- Vol. 495, 457-466
Abstract
No abstract availableKeywords
Funding Information
- Institut National de la Santé et de la Recherche Médicale
- Université Toulouse III - Paul Sabatier
This publication has 93 references indexed in Scilit:
- Reduced ceramide synthase 2 activity causes progressive myoclonic epilepsyAnnals of Clinical and Translational Neurology, 2014
- Systemic ceramide accumulation leads to severe and varied pathological consequencesEMBO Molecular Medicine, 2013
- Spinal Muscular Atrophy Associated with Progressive Myoclonic Epilepsy Is Caused by Mutations in ASAH1The American Journal of Human Genetics, 2012
- Ceramide synthases at the centre of sphingolipid metabolism and biologyBiochemical Journal, 2012
- Recessive Mutations in ELOVL4 Cause Ichthyosis, Intellectual Disability, and Spastic QuadriplegiaThe American Journal of Human Genetics, 2011
- Adult Ceramide Synthase 2 (CERS2)-deficient Mice Exhibit Myelin Sheath Defects, Cerebellar Degeneration, and HepatocarcinomasJournal of Biological Chemistry, 2009
- Prosaposin deficiency and saposin B deficiency (activator‐deficient metachromatic leukodystrophy): Report on two patients detected by analysis of urinary sphingolipids and carrying novel PSAP gene mutationsAmerican Journal of Medical Genetics Part A, 2009
- In vivo delivery of human acid ceramidase via cord blood transplantation and direct injection of lentivirus as novel treatment approaches for Farber diseaseMolecular Genetics and Metabolism, 2008
- Sphingosine-1-phosphate lyase in development and disease: Sphingolipid metabolism takes flightBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2008
- Neurolysosomal pathology in human prosaposin deficiency suggests essential neurotrophic function of prosaposinActa Neuropathologica, 2006